Cargando…
Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease
Caused by a polyglutamine expansion in the huntingtin protein, Huntington's disease leads to striatal degeneration via the transcriptional dysregulation of a number of genes, including those involved in mitochondrial biogenesis. Here we show that transglutaminase 2, which is upregulated in HD,...
Autores principales: | McConoughey, Stephen J, Basso, Manuela, Niatsetskaya, Zoya V, Sleiman, Sama F, Smirnova, Natalia A, Langley, Brett C, Mahishi, Lata, Cooper, Arthur J L, Antonyak, Marc A, Cerione, Rick A, Li, Bo, Starkov, Anatoly, Chaturvedi, Rajnish Kumar, Beal, M Flint, Coppola, Giovanni, Geschwind, Daniel H, Ryu, Hoon, Xia, Li, Iismaa, Siiri E, Pallos, Judit, Pasternack, Ralf, Hils, Martin, Fan, Jing, Raymond, Lynn A, Marsh, J Lawrence, Thompson, Leslie M, Ratan, Rajiv R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068019/ https://www.ncbi.nlm.nih.gov/pubmed/20665636 http://dx.doi.org/10.1002/emmm.201000084 |
Ejemplares similares
-
Opening up about Tissue Transglutaminase: When Conformation Matters More than Enzymatic Activity
por: Katt, William P., et al.
Publicado: (2018) -
Simultaneously Targeting Tissue Transglutaminase and
Kidney Type Glutaminase Sensitizes Cancer Cells to Acid Toxicity and
Offers New Opportunities for Therapeutic Intervention
por: Katt, William P., et al.
Publicado: (2014) -
A small molecule regulator of tissue transglutaminase conformation inhibits the malignant phenotype of cancer cells
por: Katt, William P., et al.
Publicado: (2018) -
Transglutaminase 2 Facilitates Murine Wound Healing in a Strain-Dependent Manner
por: Yiu, Ting W., et al.
Publicado: (2023) -
Transglutaminase 2 moderates the expansion of mouse abdominal aortic aneurysms
por: Griffin, Kathryn J., et al.
Publicado: (2021)